F. Duffaud, O. Mir, P. Boudu-rouquette, and S. Piperno-neumann, Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: results of a non comparative, randomised, double-blind, placebo controlled, multicentre phase II study, Lancet Oncol, 2018.

H. Kaitsiotou, M. Keul, and J. Hardick, Inhibitors to overcome secondary mutations in the stem cell factor receptor KIT, J Med Chem, vol.60, pp.8801-8816, 2017.

T. J. Lynch, D. W. Bell, and R. Sordella, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib, N Engl J Med, vol.350, pp.2129-2168, 2004.

R. Bose, S. M. Kavuri, and A. C. Searleman, Activating HER2 mutations in HER2 gene amplification negative breast cancer, Cancer Discov, vol.3, pp.224-261, 2013.
DOI : 10.1158/2159-8290.cd-12-0349
URL : http://cancerdiscovery.aacrjournals.org/content/3/2/224.full.pdf